Safety and Immunogenicity of MSB11455 in Healthy Participants
Clinical trial NCT03251339 · COMPLETED
Trial details
- NCT number
- NCT03251339
- Sponsor
- Fresenius Kabi SwissBioSim GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-21
- Primary completion
- 2018-02-05
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.